Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.
Show more...
FAQ
Aequus Pharmaceuticals 今天的股價是多少?▼
AQS.V 目前價格為 C$0.01 CAD,過去 24 小時上漲了 +0%。在圖表上更密切關注 Aequus Pharmaceuticals 股價表現。
Aequus Pharmaceuticals 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Aequus Pharmaceuticals 的股票以代號 AQS.V 進行交易。
Aequus Pharmaceuticals 的市值是多少?▼
今天 Aequus Pharmaceuticals 的市值為 663,170
Aequus Pharmaceuticals 去年的營收是多少?▼
Aequus Pharmaceuticals 去年的營收為 1.17MCAD。
Aequus Pharmaceuticals 去年的淨利是多少?▼
AQS.V 去年的淨收益為 -4.36MCAD。
Aequus Pharmaceuticals 位於哪個產業?▼
Aequus Pharmaceuticals從事於Health & Wellness產業。
Aequus Pharmaceuticals 何時完成拆股?▼
Aequus Pharmaceuticals 最近沒有進行任何拆股。
Aequus Pharmaceuticals 的總部在哪裡?▼
Aequus Pharmaceuticals 的總部位於 加拿大 的 Vancouver。